Observer AI Power Index: Alex Zhavoronkov, PhD, founder of Insilico Medicine acknowledged among 100 future-shaping leaders
Grant and Award Announcement
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 21-Nov-2025 12:11 ET (21-Nov-2025 17:11 GMT/UTC)
The Observer A.I Power Index 2025, published by Observer, the digital media chronicling the world's power players, has officially been released, recognizing 100 global leaders driving the future of artificial intelligence across industries. Insilico Medicine's founder, CEO & CBO, Alex Zhavoronkov, PhD, was selected for his unique contributions at the intersection of biotechnology and AI.
A new AI framework improves how complex systems with unequal decision-makers like smart grids – traffic networks, and autonomous vehicles – are managed. Unlike traditional models that assume equal influence and timing, this approach uses a Stackelberg-Nash game structure, where leader agents act first and followers respond optimally. It also features an event-triggered mechanism that updates decisions only when needed, cutting computational load. The result is smarter, more efficient AI that adapts to real-world uncertainty, limited resources, and hierarchical decision-making.
Strength and coordination change over the course of our lives, decreasing dramatically with age. But when it comes to the fine motor skills of our hands and fingers, this is not the case. This discovery was made by a research group led by UZH developmental pediatrician Oskar Jenni. Percentile reference curves could make reduced performance more recognizable in practice.
China’s BGI Genomics has marked its 26th anniversary with the launch of a newly developed AI-powered health management platform for the strategic commitment to global healthcare transformation. The platform enhances diagnostic efficiency and enables proactive disease prevention, creating a new standard in precision medicine.
As Saudi Arabia commemorates its 95th National Day and advances its Vision 2030 agenda, health innovation are driving a nationwide shift toward data-driven, precision-based healthcare. BGI Genomics, with its growing presence in the Kingdom and expertise in genomics and multi-omics technologies, is helping bring these goals closer to reality.
The study, published in iScience, shows that the directionality of slow waves in the cerebral cortex depends on neuronal excitability and not only on anatomy.